PerfectServe names IT vet to lead expansion of brand’s software platform

Clinical communications company PerfectServe has named a new COO to lead the company as it expands its PerfectServe Synchrony, a platform that allows clinicians to communicate about patient care.

Greg White, a healthcare IT veteran who has worked in the industry for more than 30 years, will serve as the company’s COO, according to a statement. White’s main responsibilities will be to oversee the expansion of the Synchrony program to ambulatory and post-care provider markets. Additionally, he will drive product innovation, sales, professional services, client services and network operations.

"We are fortunate to have an industry executive of Greg's caliber join our executive team," said Terry Edwards, president and CEO of PerfectServe, in a statement. "PerfectServe is at a meaningful size as a healthcare IT company, requiring different skill sets and functions to support development of our secure mobile care team collaboration and communications platform.

White was previously senior vice president and general manager of Allscripts Healthcare Solutions’ TouchWorks EMR Division. In this position, he focused on revenue growth, product quality and regulatory compliance. Prior to Allscripts, he was the founder and CEO of Gajema Software, which was later sold in 2004 to Cerner, a health information technology company based in Kansas City, Missouri.

White is expected to bring understanding of operations and product selling to hospitals, integrated delivery networks, groups practices and other provider markets to PerfectServe, which is headquartered in Knoxville, Tennessee.

“His expertise scaling an organization of sizeable growth to the next level of agility in response to market demands is fundamental in pivoting our business strategy,” Edwards said. "Greg will be working closely as my partner alongside the senior management team to navigate PerfectServe's transition over the next phase of growth.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.